Status:
COMPLETED
Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple Sclerosis
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which four additional 20-minute sequences will be added. MRI of routine care in the con...
Eligibility Criteria
Inclusion
- Patients over 18
- With MS defined according to the McDonald's revised clinical or radiological spatial and temporal dissemination criteria, with onset of symptoms \<5 years
- To benefit as part of care from an MRI with or without injection of gadolinium
- Express consent to participate in the study
- Affiliate or beneficiary of a social security scheme
Exclusion
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
June 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 24 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04705870
Start Date
June 2 2021
End Date
May 24 2023
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hhopital fondation adolphe de rothschild
Paris, Paris, France, 75019